March 29, 2020

Intracranial Stents Market | Key Players are Boston Scientific Corporation, Johnson & Johnson Services, Inc., Stryker Corporation, Penumbra, Inc., among others.

According to the latest report published by Credence Research, Inc. “Intracranial Stents Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global intracranial stent market was valued at USD 293.7 million in 2017 and is expected to reach USD 691.2 million by 2026, increasing to CAGR by 9.9 per cent from 2018 to 2026.

Market Insights

Stroke is the leading cause of disability in adults, usually due to narrowing of major intracranial arteries followed by atherosclerotic plaque deposition. The prevalence of intracranial atherosclerotic disease (ICAD) is very prevalent in the Asian population. ICAD is initially treated with antithrombotics, antihypertensive agents, statins and risk factor controls. However, in emergency cases or other complications, intracranial stenting is preferred, but the comparatively intracranial stenting rate is low, mainly due to the negative impact of the SAMMPRIS trial.

Browse Full Report Originally Published by Credence Research at

Other growth-restricting factors of the intracranial stent market include the development of healthcare infrastructure in many Asian countries, high costs of neurological surgery, the need for highly trained and skilled practitioners, and minimal product penetration. Studies such as SAMMPRIS and VISSIT concluded that aggressive drug therapy was superior to angioplasty and stenting. These results have strongly influenced key opinion leaders in support of endovascular treatment for ICAD leading to the minimization of target indications for Stryker’s Wingspan stent, which is the only approved USFDA product. However, at the beginning of 2018, results of the WEAVE study, which was not a randomized clinical trial, were found to have fewer adverse reactions in patients treated on-label with Wingspan stent, concluding that intracranial stent may be used in a specific set of high-risk ICAD patients.

The type of intracranial stents present on the market are self-expanding intracranial stents, balloon-expanding stents, and stent-assisted coil embolization. In 2017, stent-assisted coil embolization accounted for the largest market share due to key driving factors, such as being one of the initially approved stents, significantly evolving over the years and increasing prevalence of intracranial stenosis. On the basis of diseases intracranial stents market is segmented as intracranial stenosis and brain aneurysm from which intracranial stenosis has been identified as the largest market. Key factors responsible for the growth of the intracranial stenosis treatment market due to high prevalence of intracranial stenosis, technological developments in intracranial stenosis diagnostics, and increased awareness of intracranial stenosis therapy.

North America was identified as the largest market in the forecast period from 2018 to 2026 due to key factors such as increased prevalence of intracranial stenosis & brain aneurysm, developed healthcare infrastructure along with high public awareness of early diagnosis and high penetration of intracranial stents along with efficient skilled practitioners. According to the American Heart Association, atherosclerotic stenosis has been identified as the major cause of around 700,000 strokes occurring annually in the United States. As a result, overall North America is expected to remain dominant throughout the forecast period.

Market Competition Assessment:

The intracranial stents market is growing significantly and major companies present in this market are focusing on the development of safe & efficient intracranial stents. The major companies in this market are Boston Scientific Corporation, Johnson & Johnson Services, Inc., Stryker Corporation, Penumbra, Inc., Medtronic plc, Terumo Corporation, and Cook Medical among others.

Key Market Movements:

  • Increasing demand for minimally invasive surgical treatment is expected to assist the intracranial stenosis
  • Incessant development in the technology of intracranial stents will drive the demand for safe & efficient stents
  • Negative results of SAMMPRIS trial has created a negative impact of intracranial stents in the market
  • Ongoing research and development in the field of intracranial stents market is expected to assist the overall market growth in the near future

Access Free Sample Copy of Research Report:

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Type of Product Segment

  • Self-Expanding Intracranial Stents
  • Balloon Expanding Stents
  • Stent-assisted Coil Embolization

By Disease Segment

  • Brain Aneurysms
  • Intracranial Stenosis

By Geography Segment

· North America (the U.S., Rest of North America)

· Europe (U.K., Germany, France, Rest of Europe)

· Asia Pacific (China, Japan, India, Rest of Asia Pacific)

· Rest of the World (the Middle East & Africa, Latin America)

Key questions answered in this report

  • Which is the trending product type in the market preferred for intracranial stents & Why?
  • What are the recent market strategies applied by key players & competitive analysis specific to intracranial stents market?
  • Which are the major geographical markets (regions and countries) in intracranial stents market?
  • Which is the largest and fastest growing intracranial stent types globally?
  • How is the competitive landscape of intracranial stents market and policies of major players present in this industry?

Access Free Sample Copy of Research Report:

Leave a Reply

Your email address will not be published. Required fields are marked *